These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19432240)

  • 21. [Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2002; (1):23-5. PubMed ID: 11877967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
    Adriazola Semino M; Lozano Ortega JL; García Cobo E; Tejeda Báñez E; Romero Rodríguez F
    Arch Esp Urol; 1992 Apr; 45(3):211-3. PubMed ID: 1384438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
    Champault G; Patel JC; Bonnard AM
    Br J Clin Pharmacol; 1984 Sep; 18(3):461-2. PubMed ID: 6207850
    [No Abstract]   [Full Text] [Related]  

  • 25. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
    Squadrito F; Morgia G
    Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the editorResponse to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1-10.
    Arena S
    Expert Opin Drug Saf; 2016 Oct; 15(10):1449. PubMed ID: 27558894
    [No Abstract]   [Full Text] [Related]  

  • 27. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia.
    Marks LS; Tyler VE
    Urology; 1999 Mar; 53(3):457-61. PubMed ID: 10096366
    [No Abstract]   [Full Text] [Related]  

  • 28. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance.
    Gallo E; Maggini V; Lombardi N; Crescioli G; Sivelli F; Vannacci A; Firenzuoli F
    Br J Clin Pharmacol; 2022 May; 88(5):2441-2443. PubMed ID: 34747053
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia.
    Borovskaya TG; Fomina TI; Ermolaeva LA; Vychuzhanina AV; Pakhomova AV; Poluektova ME; Shchemerova YA
    Bull Exp Biol Med; 2013 May; 155(1):67-70. PubMed ID: 23667874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Permixon in the treatment of benign prostatic hyperplasia].
    Gorilovskiĭ LM
    Ter Arkh; 1995; 67(8):62-4. PubMed ID: 7482341
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute liver damage due to Serenoa repens: a case report.
    Lapi F; Gallo E; Giocaliere E; Vietri M; Baronti R; Pieraccini G; Tafi A; Menniti-Ippolito F; Mugelli A; Firenzuoli F; Vannacci A
    Br J Clin Pharmacol; 2010 May; 69(5):558-60. PubMed ID: 20573093
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hot flashes in a young girl: a wake-up call concerning Serenoa repens use in children.
    Miroddi M; Carnì A; Mannucci C; Moleti M; Navarra M; Calapai G
    Pediatrics; 2012 Nov; 130(5):e1374-6. PubMed ID: 23027164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use the INN to avoid confusion between drugs.
    Prescrire Int; 2009 Oct; 18(103):214. PubMed ID: 19882793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: 15 Years' Survey of Safety and Efficacy of Serenoa Repens Extract in Benign Prostatic Hyperplasia Patients with Risk of Progression.
    Kaplan SA
    J Urol; 2020 Sep; 204(3):593-594. PubMed ID: 32552493
    [No Abstract]   [Full Text] [Related]  

  • 36. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.
    De Monte C; Carradori S; Granese A; Di Pierro GB; Leonardo C; De Nunzio C
    BMC Urol; 2014 Aug; 14():63. PubMed ID: 25112532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proven and unproven therapy for benign prostatic hyperplasia.
    DiPaola RS; Morton RA
    N Engl J Med; 2006 Feb; 354(6):632-4. PubMed ID: 16467551
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of biologically active substances of animal and plant origin on prooxidant-antioxidant balance in rats with experimental prostatic hyperplasia].
    Belostotskaia LI; Nikitchenko IuV; Gomon ON; Chaĭka LA; Bondar' VV; Dziuba VN
    Eksp Klin Farmakol; 2006; 69(4):66-8. PubMed ID: 16995443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is saw palmetto used for, and does it interact with any medications?
    Gerber G
    Health News; 2000 Jun; 6(6):10. PubMed ID: 10917733
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preventive and curative action of a bark extract from an African plant, Pygeum africanum, on experimental prostatic adenoma in rats].
    Thieblot L; Berthelay S; Berthelay J
    Therapie; 1971; 26(3):575-80. PubMed ID: 4107111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.